The combined use of corticosteroids and antibiotics is a common practice in treating ocular surface inflammatory conditions where corticosteroid therapy is necessary and there's a risk of superficial bacterial infection. Loteprednol etabonate 0.5% and tobramycin 0.3% (LE/T) is one such combination that has been examined in trials for blepharokeratoconjunctivitis.